| Product Code: ETC9952542 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, the United Kingdom import trend for posaconazole showed a modest growth rate of 0.67%, with a compound annual growth rate (CAGR) of 2.33% from 2020 to 2024. This stable but slight increase in import momentum could be attributed to steady demand for the product within the UK pharmaceutical market, indicating a consistent need for posaconazole during this period.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United Kingdom (UK) Posaconazole Market Overview |
3.1 United Kingdom (UK) Country Macro Economic Indicators |
3.2 United Kingdom (UK) Posaconazole Market Revenues & Volume, 2021 & 2031F |
3.3 United Kingdom (UK) Posaconazole Market - Industry Life Cycle |
3.4 United Kingdom (UK) Posaconazole Market - Porter's Five Forces |
3.5 United Kingdom (UK) Posaconazole Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United Kingdom (UK) Posaconazole Market Revenues & Volume Share, By Applications, 2021 & 2031F |
3.7 United Kingdom (UK) Posaconazole Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.8 United Kingdom (UK) Posaconazole Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United Kingdom (UK) Posaconazole Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of invasive fungal infections in the UK |
4.2.2 Growing awareness about the benefits of posaconazole in treating fungal infections |
4.2.3 Rise in research and development activities for new formulations and applications of posaconazole |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for approval and commercialization of posaconazole products in the UK |
4.3.2 Competition from alternative antifungal medications in the market |
5 United Kingdom (UK) Posaconazole Market Trends |
6 United Kingdom (UK) Posaconazole Market, By Types |
6.1 United Kingdom (UK) Posaconazole Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Injection, 2021- 2031F |
6.1.4 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Delayed-release Tablets, 2021- 2031F |
6.1.5 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Oral Suspension, 2021- 2031F |
6.1.6 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United Kingdom (UK) Posaconazole Market, By Applications |
6.2.1 Overview and Analysis |
6.2.2 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Prophylaxis of Invasive Aspergillus, 2021- 2031F |
6.2.3 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Candida Infections, 2021- 2031F |
6.2.4 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Oropharyngeal Candidiasis(OPC), 2021- 2031F |
6.2.5 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Invasive Infections by Candida, 2021- 2031F |
6.2.6 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Mucor and Aspergillus Species, 2021- 2031F |
6.2.7 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Other, 2021- 2031F |
6.3 United Kingdom (UK) Posaconazole Market, By End-Users |
6.3.1 Overview and Analysis |
6.3.2 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Clinics, 2021- 2031F |
6.3.3 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.4 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Diagnostic centres, 2021- 2031F |
6.3.5 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United Kingdom (UK) Posaconazole Market, By Distribution Channel |
6.4.1 Overview and Analysis |
6.4.2 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.4.3 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
6.4.4 United Kingdom (UK) Posaconazole Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
7 United Kingdom (UK) Posaconazole Market Import-Export Trade Statistics |
7.1 United Kingdom (UK) Posaconazole Market Export to Major Countries |
7.2 United Kingdom (UK) Posaconazole Market Imports from Major Countries |
8 United Kingdom (UK) Posaconazole Market Key Performance Indicators |
8.1 Number of clinical trials conducted for posaconazole in the UK |
8.2 Adoption rate of posaconazole in different healthcare settings |
8.3 Number of partnerships or collaborations for the development and distribution of posaconazole formulations in the UK |
9 United Kingdom (UK) Posaconazole Market - Opportunity Assessment |
9.1 United Kingdom (UK) Posaconazole Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United Kingdom (UK) Posaconazole Market Opportunity Assessment, By Applications, 2021 & 2031F |
9.3 United Kingdom (UK) Posaconazole Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.4 United Kingdom (UK) Posaconazole Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United Kingdom (UK) Posaconazole Market - Competitive Landscape |
10.1 United Kingdom (UK) Posaconazole Market Revenue Share, By Companies, 2024 |
10.2 United Kingdom (UK) Posaconazole Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |